NEUREN PHARMACEUTICALS LIMITED earnings per share and revenue

NEU earnings per share for the last semiannual are 0.06 AUD whereas the estimation was 0.11 AUD which accounts for -44.02% surprise. Company revenue for the same period amounts to 32.11 M AUD despite the estimated figure of 30.66 M AUD. Estimated earnings per share for the next semiannual are 0.98 AUD, and revenue is expected to reach 182.22 M AUD. Also watch annual changes over time to get a bigger picture of NEU earnings per share and revenue dynamics.